Composition
- Active ingredients
- EMTRICITABINE 200MG; RILPIVIRINE 25MG; TENOFOVIR ALAFENAMIDE 25MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA214058.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Emtricitabine; Rilpivirine; Tenofovir Alafenamide
- Active substance
- emtricitabine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Cipla Limited
- Status
- Tentative approval
- FDA approval
- 27 Sept 2022
- Application
- ANDA214058-001